Genetically modified non-human having humanized gamma and delta TCR variable genes
US-2024114883-A1 · Apr 11, 2024 · US
US10136621B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10136621-B2 |
| Application number | US-201816011631-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2018 |
| Priority date | Nov 15, 2013 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for the production of reproductively sterile fish and aquatic animals for aquaculture, the aquarium trade, and control of invasive species are described. The methods include disruption of gonadal development through the administration of compounds that lead to the failure of fertile gonadal development. Compounds may be delivered to the eggs prior to fertilization or water activation or post fertilization and water activation by contacting unfertilized or pre-water-activated fertilized eggs or fertilized eggs in an immersion medium including the compound of interest. Compounds may be conjugated with a molecular transporter compound effective for chorionic transport of the conjugate. The compounds may be antisense Morpholino oligomers that are capable of effectively suppressing the expression of the dead end gene or other essential genes for germ cell development in fish and other egg-producing aquatic animals.
Opening claim text (preview).
What is claimed is: 1. A composition for treatment of fish eggs to render fish produced therefrom reproductively sterile, said composition comprising an anti-sense Morpholino oligomer conjugated to an octaguanidine dendrimer molecular transporter, wherein said anti-sense Morpholino oligomer suppresses the translation of dead end gene in said fish. 2. The composition of claim 1 , wherein said anti-sense Morpholino oligomer comprises an oligomer selected from the group consisting of oligomers of SEQ ID NOS: 1-4 and variants thereof. 3. The composition of claim 1 , comprising an aqueous medium containing the anti-sense Morpholino oligomer. 4. The composition of claim 1 wherein the fish eggs are unfertilized or pre-water-activated fertilized fish eggs. 5. The composition of claim 4 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 1 to 20 μM. 6. The composition of claim 4 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 3 to 15 μM. 7. The composition of claim 4 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 5 to 10 μM. 8. The composition of claim 1 , wherein the fish eggs are fertilized fish eggs. 9. The composition of claim 8 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 20 to 80 μM. 10. The composition of claim 8 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 40 to 60 μM. 11. The composition of claim 1 , wherein the anti-sense Morpholino oligomer is conjugated with 2-[(4-nitrophenyl)oxycarbonylhexamethylenecarbonylpiperazinyl]-4,6-bis {di [di(trifluoro-acetamidohexyl)-aminocarbonyloxyethyl]amino}triazine. 12. The composition of claim 1 , wherein the anti-sense Morpholino oligomer comprises an oligomer selected from the group consisting of oligomers of SEQ ID NOS: 1-4. 13. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises an oligomer of SEQ ID NO: 1. 14. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises an oligomer of SEQ ID NO: 2. 15. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises an oligomer of SEQ ID NO: 3. 16. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises oligomer of SEQ ID NO: 4. 17. The composition of claim 1 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 or a variant thereof. 18. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 1 or a variant thereof. 19. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 2 or a variant thereof. 20. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 3 or a variant thereof. 21. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 4 or a variant thereof. 22. The composition of claim 1 , wherein the anti-sense Morpholino oligomer conjugated to the octaguanidine dendrimer molecular transporter is effective in reproductively sterilizing said fish eggs by the fish eggs being immersed in an immersion medium comprising an effective amount of said anti-sense Morpholino oligomer conjugated to said octaguanidine dendrimer molecular transporter.
inducing loss of function, i.e. knock out · CPC title
Monitoring or fighting invasive species · CPC title
Antisense · CPC title
Knock-out vertebrates · CPC title
Animal zootechnically ameliorated · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.